[
  {
    "ts": null,
    "headline": "Moderna (NasdaqGS:MRNA) Up 11% Despite Patent Lawsuit Challenges",
    "summary": "Moderna (NasdaqGS:MRNA) saw an 11% increase in share price over the last week, likely influenced by recent legal and financial developments. The announcement of multiple international lawsuits from Genevant Sciences and Arbutus Biopharma over patent issues may have injected uncertainty, but the stock's rise could suggest investor confidence in Moderna's ability to navigate these challenges. The company's financial performance update, with significant declines in both quarterly revenue and...",
    "url": "https://finnhub.io/api/news?id=4e55b7ce9c3a868e73e0c9e4c3ed7d33dddb2c10d4300073f4b5c86a5ee8cccb",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741801101,
      "headline": "Moderna (NasdaqGS:MRNA) Up 11% Despite Patent Lawsuit Challenges",
      "id": 133193262,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna (NasdaqGS:MRNA) saw an 11% increase in share price over the last week, likely influenced by recent legal and financial developments. The announcement of multiple international lawsuits from Genevant Sciences and Arbutus Biopharma over patent issues may have injected uncertainty, but the stock's rise could suggest investor confidence in Moderna's ability to navigate these challenges. The company's financial performance update, with significant declines in both quarterly revenue and...",
      "url": "https://finnhub.io/api/news?id=4e55b7ce9c3a868e73e0c9e4c3ed7d33dddb2c10d4300073f4b5c86a5ee8cccb"
    }
  },
  {
    "ts": null,
    "headline": "3 Reasons MRNA is Risky and 1 Stock to Buy Instead",
    "summary": "Moderna has gotten torched over the last six months - since September 2024, its stock price has dropped 51.2% to $33.99 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move.",
    "url": "https://finnhub.io/api/news?id=2909d9eafb05877a3ddbffea3a595461ee724a8d4fc4405e97e9c18928b66c79",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1741770341,
      "headline": "3 Reasons MRNA is Risky and 1 Stock to Buy Instead",
      "id": 133193264,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "MRNA",
      "source": "Yahoo",
      "summary": "Moderna has gotten torched over the last six months - since September 2024, its stock price has dropped 51.2% to $33.99 per share. This was partly due to its softer quarterly results and might have investors contemplating their next move.",
      "url": "https://finnhub.io/api/news?id=2909d9eafb05877a3ddbffea3a595461ee724a8d4fc4405e97e9c18928b66c79"
    }
  }
]